Within the types dimension of Carotenoid market taxonomy, three core categories emerge: natural, synthetic, and microbial‑derived carotenoids. Natural carotenoids, extracted from plant sources (e.g., carrots, tomatoes) or algae (e.g., Haematococcus pluvialis), command the majority of volume due to regulatory preference for clean‑label ingredients; sub‑types such as beta‑carotene, lycopene, lutein, and zeaxanthin each address distinct functional claims across applications. Synthetic carotenoids, produced via chemical routes, occupy a niche where cost efficiency and batch consistency outweigh natural sourcing constraints, primarily serving bulk colorant needs in food processing. Microbial‑derived carotenoids, generated through engineered yeast or bacterial strains, are gaining traction for their scalability and sustainability profile, especially for high‑value compounds like astaxanthin. While quantitative market shares for these type categories are not depicted in the chart, their relative contributions are evident: natural variants dominate the revenue base, synthetic forms sustain lower‑margin segments, and microbial sources represent a growth frontier within the Carotenoid market.